1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
Plenary Session
English - October 23, 2018 21:17 - 1 hour - 68.7 MB - ★★★★★ - 722 ratingsScience Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 1.17 BONUS! Interpretation of Cancer Clinical Trials
Next Episode: 1.19 BONUS! Introduction to Cancer Drug Policy
In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations.
IMpassion130: doi.org/10.1056/NEJMoa1809615
Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters